These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 18311804)
1. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Yamazaki T; Masumoto J; Agematsu K; Sawai N; Kobayashi S; Shigemura T; Yasui K; Koike K Arthritis Rheum; 2008 Mar; 58(3):864-8. PubMed ID: 18311804 [TBL] [Abstract][Full Text] [Related]
2. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Hawkins PN; Lachmann HJ; Aganna E; McDermott MF Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505 [TBL] [Abstract][Full Text] [Related]
3. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment. Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561 [TBL] [Abstract][Full Text] [Related]
4. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra. Dalgic B; Egritas O; Sari S; Cuisset L Pediatr Nephrol; 2007 Sep; 22(9):1391-4. PubMed ID: 17486372 [TBL] [Abstract][Full Text] [Related]
5. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra. Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084 [TBL] [Abstract][Full Text] [Related]
6. "Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies. Hedrich CM; Bruck N; Paul D; Hahn G; Gahr M; Rösen-Wolff A Rheumatol Int; 2012 Sep; 32(9):2629-36. PubMed ID: 21833523 [TBL] [Abstract][Full Text] [Related]
7. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Mirault T; Launay D; Cuisset L; Hachulla E; Lambert M; Queyrel V; Quemeneur T; Morell-Dubois S; Hatron PY Arthritis Rheum; 2006 May; 54(5):1697-700. PubMed ID: 16646042 [TBL] [Abstract][Full Text] [Related]
8. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome. Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991 [TBL] [Abstract][Full Text] [Related]
9. A cryopyrin-associated periodic syndrome with joint destruction. Lequerré T; Vittecoq O; Saugier-Veber P; Goldenberg A; Patoz P; Frébourg T; Le Loët X Rheumatology (Oxford); 2007 Apr; 46(4):709-14. PubMed ID: 17178739 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. Kuemmerle-Deschner JB; Tyrrell PN; Koetter I; Wittkowski H; Bialkowski A; Tzaribachev N; Lohse P; Koitchev A; Deuter C; Foell D; Benseler SM Arthritis Rheum; 2011 Mar; 63(3):840-9. PubMed ID: 21360513 [TBL] [Abstract][Full Text] [Related]
11. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Maksimovic L; Stirnemann J; Caux F; Ravet N; Rouaghe S; Cuisset L; Letellier E; Grateau G; Morin AS; Fain O Rheumatology (Oxford); 2008 Mar; 47(3):309-10. PubMed ID: 18174231 [TBL] [Abstract][Full Text] [Related]
12. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene. Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413 [TBL] [Abstract][Full Text] [Related]
13. Muckle-Wells Syndrome: A Case Report with an NLRP3 T348M Mutation. Naz Villalba E; Gomez de la Fuente E; Caro Gutierrez D; Pinedo Moraleda F; Yanguela Rodilla J; Mazagatos Angulo D; López Estebaranz JL Pediatr Dermatol; 2016 Sep; 33(5):e311-4. PubMed ID: 27435956 [TBL] [Abstract][Full Text] [Related]
14. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411 [TBL] [Abstract][Full Text] [Related]
16. Twenty year follow up of a patient with a new de-novo NLRP3 mutation (S595G) and CINCA syndrome. Kanariou M; Dracou C; Spanou K; Möller J; Rösen-Wolff A; Schuster V; Roesler J Klin Padiatr; 2009; 221(6):379-81. PubMed ID: 19890791 [TBL] [Abstract][Full Text] [Related]
17. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies. Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262 [TBL] [Abstract][Full Text] [Related]